Obesity And Saxenda® Knowledge Checks - I

Approved & Edited by ProProfs Editorial Team

The editorial team at ProProfs Quizzes consists of a select group of subject experts, trivia writers, and quiz masters who have authored over 10,000 quizzes taken by more than 100 million users. This team includes our in-house seasoned quiz moderators and subject matter experts. Our editorial experts, spread across the world, are rigorously trained using our comprehensive guidelines to ensure that you receive the highest quality quizzes.

Learn about Our Editorial Process

| By Hsn_rules

Hsn_rules

Community Contributor

Quizzes Created: 1 | Total Attempts: 80

Questions: 6 | Attempts: 82 | Updated: Mar 15, 2023

Questions

Settings

Create your own Quiz

Share on Facebook Share on Twitter Share on Whatsapp Share on Pinterest Share on Email Copy to Clipboard Embed on your website

Obesity And Saxenda� Knowledge Checks - I - Quiz

This short quiz is developed to enrich the understanding of obesity and Saxenda®

Questions and Answers

1.

Which international agencies Considered obesity as a global health challenge requiring a “chronic disease management model” ?
- A.
  
  World Health Organization (WHO)
- B.
  
  European Medicines Agency (EMA)
- C.
  
  American Medical Association (AMA)
- D.
  
  Canadian Medical Association (CMA)
- E.
  
  The Obesity Society (TOS)
Correct Answer(s)
A. World Health Organization (WHO)
B. European Medicines Agency (EMA)
C. American Medical Association (AMA)
D. Canadian Medical Association (CMA)
E. The Obesity Society (TOS)

Explanation
The WHO has declared obesity as a disease in 2000, and other agencies reached the same decision afterward

Rate this question:
2.

Weight gain occurs when energy intake exceeds energy expenditure
- A.
  
  True
- B.
  
  False
Correct Answer
A. True

Explanation
Obesity is a result of an energy imbalance

Rate this question:
3.

In a 3 years clinical trial, losing weight with Saxenda®, delays the onset of T2DM by ......
- A.
  
  60%
- B.
  
  70%
- C.
  
  80%
- D.
  
  90%
Correct Answer
C. 80%

Explanation
Losing weight with Saxenda®, delays the onset of T2DM in by 80%, This result was proven in the phase 3 trials for Saxenda® (SCALE studyPi-Sunyer et al. N Engl J Med. 2015;373(1):11-22.)

Rate this question:
4.

During the SCALE program, Saxenda® was found to reduce the followings
- A.
  
  Lipid Profile
- B.
  
  Systolic Blood Pressure
- C.
  
  Glucose Level
- D.
  
  Weight
Correct Answer(s)
A. Lipid Profile
B. Systolic Blood Pressure
C. Glucose Level
D. Weight

Explanation
This result was proven in the phase 3 trials for Saxenda®(SCALE studyle Roux et al. Lancet. 2017 Apr 08;389(10077):1399-409.)

Rate this question:
5.

Saxenda® is the only GLP-1 agonist approved for Weight reduction, it had approvals from ……
- A.
  
  FDA
- B.
  
  EMA
- C.
  
  Iraq MOH
- D.
  
  All the above
Correct Answer
D. All the above

Explanation
Saxenda® has FDA, EMA and Iraq MOH approvals and it’s approved as an adjunct to a reduced- calorie diet and increased physical activity for chronic weight management in adults with obesity (BMI of ≥30 kg/m2) or who are overweight (BMI of ≥27 kg/m2) in the presence of at least one weight-related comorbid condition.

Rate this question:
6.

Every 1 Kg gain in Weight is associated with ……… increase in risk of diabetes.
- A.
  
  3%
- B.
  
  6%
- C.
  
  9%
- D.
  
  12%
Correct Answer
C. 9%

Explanation
In an 8 years study in the US, for every Kg increase in self-reported weight, diabetes increased by 9% (Mokdad AH, Ford ES, Bowman BA, Nelson DE, Engelgau MM, Vinicor F, et al. Diabetes trends in the U.S, Diabetes Care. 2000 Sep;23(9):1278-83.).

Rate this question:

Quiz Review Timeline +

Our quizzes are rigorously reviewed, monitored and continuously updated by our expert board to maintain accuracy, relevance, and timeliness.

Current Version
Mar 15, 2023

Quiz Edited by
ProProfs Editorial Team
Apr 04, 2020

Quiz Created by
Hsn_rules

Obesity And Saxenda® Knowledge Checks - I

Which international agencies Considered obesity as a global health challenge requiring a “chronic disease management model” ?

Weight gain occurs when energy intake exceeds energy expenditure

In a 3 years clinical trial, losing weight with Saxenda®, delays the onset of T2DM by ......

During the SCALE program, Saxenda® was found to reduce the followings

Saxenda® is the only GLP-1 agonist approved for Weight reduction, it had approvals from ……

Every 1 Kg gain in Weight is associated with ……… increase in risk of diabetes.